Federal contract award
75N95022C00031
GENETICS OF ALZHEIMER'S DISEASE AND RELATED DEMENTIAS IN LATIN AMERICA
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 541380 — Testing Laboratories and Services |
| PSC | Q301 — Reference Laboratory Testing |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $3.0M |
| Current contract value | $3.0M |
| Potential contract value / ceiling | $4.0M |
| Start date | Sep 30, 2022 |
| Current end date | Apr 30, 2025 |
| Potential end date | Apr 30, 2025 |
| Latest award activity | Apr 30, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 7 of 7 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 30, 2025 | P00006 | $0 | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI NOTICE OF TERMINATION FOR CONVENIENCE. GENETICS OF ALZHEIMER'S DISEASE AND RELATED DEMENTIAS IN LATIN AMERICA |
| Jan 31, 2025 | P00005 | $0 | GENETICS OF ALZHEIMER'S DISEASE AND RELATED DEMENTIAS IN LATIN AMERICA |
| Nov 21, 2024 | P00004 | $0 | GENETICS OF ALZHEIMER'S DISEASE AND RELATED DEMENTIAS IN LATIN AMERICA |
| Aug 16, 2024 | P00003 | $967.6K | GENETICS OF ALZHEIMER'S DISEASE AND RELATED DEMENTIAS IN LATIN AMERICA |
| Feb 7, 2024 | P00002 | $0 | GENETICS OF ALZHEIMER'S DISEASE AND RELATED DEMENTIAS IN LATIN AMERICA |
| Sep 28, 2023 | P00001 | $961.2K | GENETICS OF ALZHEIMER'S DISEASE AND RELATED DEMENTIAS IN LATIN AMERICA |
| Sep 26, 2022 | 0 | $1.1M | GENETICS OF ALZHEIMER'S DISEASE AND RELATED DEMENTIAS IN LATIN AMERICA |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.